Device Trial Radar · NCT04420702
Diffusion Basis Spectrum Imaging of the Prostate
Last checked: Nov 19, 2026Latest source record: Nov 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
500
Planned (sponsor's estimate)
Start
Feb 27, 2020
Primary completion
May 31, 2027
Study completion May 31, 2027
Sponsor
- Lead sponsor
- Washington University School of MedicineAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- American Cancer Society, Inc.; The Foundation for Barnes-Jewish Hospital; Midwest Stone Institute.; National Cancer Institute (NCI)
- First posted
- Jun 9, 2020
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- Single (investigator)
- Primary purpose
- Diagnostic
- FDA-regulated device
- Yes
- Who can join
- Male only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Diffusion Basis Spectrum Imaging (DBSI) represents a potential leap forward in improving prostate cancer early detection: a non-invasive and accurate imaging test for clinically significant prostate cancer.
Conditions
- Prostate Cancer
Interventions
MRI with DBSI analysisDevice
-The procedure will take approximately 1 hour of the participant's time
Primary outcomes
What the sponsor says the trial is designed to measure.
- Area under the curve (AUC) comparison from biopsy and DBSITime frame: Up to 12 weeks
- Receiver operating characteristic (ROC) comparison from biopsy to DBSITime frame: Up to 12 weeks
- Prostate sector analysis as measured by comparison of the highest Gleason score from each of the 10 biopsy sectors to the DBSI predicted pathology from each sectorTime frame: Up to 12 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Washington University School of Medicine
St Louis, Missouri · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.